« Back
Home /
Ranibizumab

Ranibizumab

Item no.	TMO-T9928-5mg
Manufacturer	TargetMol
CASRN	347396-82-1
Amount	5 mg
Quantity options	10 mg 1 mg 25 mg 50 mg 5 mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	347396-82-1
Shipping condition	Cool pack
Available
Manufacturer - Targets	VEGFR
Shipping Temperature	cool pack
Storage Conditions	-20°
Molecular Weight	48 kDa
Description	Ranibizumab is a humanized monoclonal antibody fragment designed to target and inhibit vascular endothelial growth factor (VEGF), including VEGF110, VEGF121, and VEGF165. Ranibizumab's ability to selectively target and neutralize VEGF-A isoforms has made it a crucial component of research and treatment strategies for wet wet age-related macular degeneration (AMD).
Pathways	Angiogenesis\|\|\|Tyrosine Kinase/Adaptors

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T9928-5mg-datasheet.pdf

TMO-T9928-5mg-safety-datasheet.pdf